Holub M C, Szalai C, Polgár A, Tóth S, Falus A
Department of Genetics, Cell- and Immunobiology, Semmelweis University of Medicine, Budapest, Hungary.
Immunol Lett. 1999 May 3;68(1):121-4. doi: 10.1016/s0165-2478(99)00040-1.
Receptors for interleukin-6 (IL-6) occur in body fluids in soluble form, as well. This is an approx. 50 kDa protein with the ability to bind IL-6. The soluble IL-6 receptor (sIL-6R)/IL-6 complex can attach to membrane anchored gp130, a molecule associated with the signal transduction induced by IL-6 and by other related cytokines. Earlier we described the appearance of sIL-6R in various body fluids of autoimmune patients. In this study using reverse transcriptase polymerase chain reaction (RT-PCR) we isolated and characterised a truncated form of amplified cDNA reverse-transcribed from IL-6 receptor mRNA both from human hepatoma cell line HepG2 and mononuclear cells from inflammatory bowel disease (IBD) patients. Using digestion by Pvu II restriction endonuclease and direct nucleotide sequencing we conclude that alternative splicing is likely involved in generation of sIL-6R. Our further experiments suggest that IL-6 and recombinant sIL-6R themselves do not influence the alternative splicing of IL-6 receptor gene.
白细胞介素-6(IL-6)的受体也以可溶性形式存在于体液中。这是一种约50 kDa的蛋白质,具有结合IL-6的能力。可溶性IL-6受体(sIL-6R)/IL-6复合物可附着于膜锚定的gp130,gp130是一种与IL-6和其他相关细胞因子诱导的信号转导相关的分子。此前我们描述了sIL-6R在自身免疫患者各种体液中的出现情况。在本研究中,我们使用逆转录聚合酶链反应(RT-PCR)从人肝癌细胞系HepG2和炎症性肠病(IBD)患者的单核细胞中分离并鉴定了从IL-6受体mRNA逆转录得到的扩增cDNA的截短形式。通过Pvu II限制性内切酶消化和直接核苷酸测序,我们得出结论,选择性剪接可能参与了sIL-6R的产生。我们的进一步实验表明,IL-6和重组sIL-6R本身不会影响IL-6受体基因的选择性剪接。